Offering consulting services and innovative business tools, our goal is to help practices to better understand the environment in which they operate. What has evolved over time is a company focused on all aspects of the healthcare market that pertain to physicians, from insurance company contracting, to policies and procedures, and how those affect revenue and delivery of services to patients. We deliver expert advice and solutions for improving practice workflow, operations, marketing, social media, and patient education. We provide access to information that can prove enlightening rather than confusing.
As our team has grown, so has our ability to meet the varied needs of our clients, resulting in the creation of our two sister companies, Patient Centered Solutions, a division that is exclusively focused on helping practices achieve Patient Centered Medical Home status, and IPMSO which enables independent practices to harness group buying power and top-tier medical supply pricing.
Founded in January 2007 by Susanne Madden, The Verden Group is a visionary consulting firm focused on shaping the landscape of advocacy by empowering medical practices to navigate through the increasingly complex business of healthcare, and to advocate on their own behalf to insurers and regulators.
Outsourcing chronic care management can have many benefits for small practices. Here are tips on how to successfully implement a CCM program that would be advantageous for both your practice and patients.
"Successfully implementing a CCM program starts with laying the operational groundwork: integrating new staff and installing healthIT software. Committing time and resources into integrating remote care managers early on is critical to reaping the benefits long term. By treating remote care coordinators as true extensions of your staff, adapting to the culture, tone, and workflow of your practice, they eventually become integral parts of practice operations, and in some cases, may even be willing to work in the office a few days a week to get additional face-to-face time with practice staff and patients. This frees up existing staff to manage other important tasks."
Pfizer reports positive results for COVID-19 vaccine in children. Read the latest here.
"Pfizer and COVID-19 vaccine development partner BioNTech reported Monday positive topline results from a pivotal trial of the vaccine in children aged 5 to 11 years. The vaccine was determined to be safe and well tolerated in the youngest age group yet to receive the 2-shot series, according to a Pfizer press statement.
Results of the phase 2/3 trial showed a robust neutralizing antibody response to the 2-dose regimen of 10 µg administered 21 days apart—a dose smaller than the 30-µg given to people aged ≥12 years. The antibody responses among the younger volunteers were comparable to that seen in trials of the vaccine in those aged 16 to 25 years, according to the company. Side effects, too, were comparable to those seen in the older cohort."
The AAP has new recommendations for using consistent terminology to describe and classify unexpected and unexplained infant deaths.
"Throughout the years, many new terms have been used to classify infant deaths to reflect whether they are believed to be accidental or undetermined or fall under other categories," said Dr. Vincent J. Palusci, MD, MS, FAAP, a co-author of the report.
"This has led to inconsistencies in terms used, which in turn increases the chances of communication errors and misunderstandings. Our goal is to establish uniform and shared terminology so that we can best support families after their loss and work to prevent more deaths."